Cardiovascular and autonomic phenotype of db/db diabetic mice

被引:79
|
作者
Senador, Danielle
Kanakamedala, Keerthy
Irigoyen, Maria Claudia [2 ]
Morris, Mariana
Elased, Khalid M. [1 ]
机构
[1] Wright State Univ, Dept Pharmacol & Toxicol, Boonshoft Sch Med, Dayton, OH 45435 USA
[2] Univ Sao Paulo, Sch Med, Hypertens Unit, Inst Heart InCor, Sao Paulo, Brazil
关键词
HEART-RATE-VARIABILITY; BETA-CELL FUNCTION; BLOOD-PRESSURE; RECEPTOR ANTAGONISM; GLUCOSE-TOLERANCE; SPECTRAL-ANALYSIS; ANGIOTENSIN; LOSARTAN; INSULIN; HYPERTENSION;
D O I
10.1113/expphysiol.2008.046474
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The db/db mice serve as a good model for type 2 diabetes characterized by hyperinsulinaemia and progressive hyperglycaemia. There are limited and conflicting data on the cardiovascular changes in this model. The aim of the present study was to characterize the cardiovascular and autonomic phenotype of male db/db mice and evaluate the role of angiotensin II AT(1) receptors. Radiotelemetry was used to monitor 24 h blood pressure (BP) in mice for 8 weeks. Parameters measured were mean arterial pressure (MAP), heart rate (HR) and their variabilities. In 8-week-old db/db mice, the MAP and BP circadian rhythms were not different from age-matched control mice, while HR and locomotor activity were decreased. With ageing, MAP gradually increased in db/db mice, and the 12 h light values did not dip significantly from the 12 h dark periods. In 14-week-old mice, MAP was increased during light (101 +/- 1 versus 117 +/- 2 mmHg, P < 0.01; control versus db/db mice) and dark phases (110 +/- 1.7 versus 121 +/- 3.1 mmHg, P < 0.01; control versus db/db mice). This increase in MAP was associated with a significant increase in plasma angiotensin-converting enzyme activity and angiotensin II levels. Chronic treatment with losartan (10 mg kg(-1) day(-1)) blocked the increase in MAP in db/db mice, with no effect in control animals. Spectral analysis was used to monitor autonomic cardiovascular function. The circadian rhythm observed in systolic arterial pressure variance and its low-frequency component in control mice was absent in db/db mice. There were no changes in HR variability and spontaneous baroreflex sensitivity between control and db/db mice. The results document an age-related increase in MAP in db/db mice, which can be reduced by antagonism of angiotensin II AT(1) receptors, and alterations in autonomic balance and components of the renin-angiotensin system.
引用
收藏
页码:648 / 658
页数:11
相关论文
共 50 条
  • [1] DIABETIC-RETINOPATHY IN DB DB MICE
    MIDENA, E
    SEGATO, T
    RADIN, S
    DIGIORGIO, G
    PIERMAROCCHI, S
    MENEGHINI, F
    [J]. DIABETOLOGIA, 1986, 29 (08) : A571 - A571
  • [2] Neurobehavioral deficits in db/db diabetic mice
    Sharma, Ajaykumar N.
    Elased, Khalid M.
    Garrett, Teresa L.
    Lucot, James B.
    [J]. PHYSIOLOGY & BEHAVIOR, 2010, 101 (03) : 381 - 388
  • [3] Diabetic Hypertensive Leptin Receptor-Deficient db/db Mice Develop Cardioregulatory Autonomic Dysfunction
    Goncalves, Andrey C. da Costa
    Tank, Jens
    Diedrich, Andre
    Hilzendeger, Aline
    Plehm, Ralph
    Bader, Michael
    Luft, Friedrich C.
    Jordan, Jens
    Gross, Volkmar
    [J]. HYPERTENSION, 2009, 53 (02) : 387 - 392
  • [4] Circadian phenotyping of obese and diabetic db/db mice
    Grosbellet, Edith
    Dumont, Stephanie
    Schuster-Klein, Carole
    Guardiola-Lemaitre, Beatrice
    Pevet, Paul
    Criscuolo, Francois
    Challet, Etienne
    [J]. BIOCHIMIE, 2016, 124 : 198 - 206
  • [5] PERIPHERAL NEUROPATHY IN DIABETIC (DB-DB) MICE
    CARTWRIGHT, TR
    MOORE, SA
    OCONNOR, BL
    FELTEN, DL
    PETERSON, RG
    [J]. CLINICAL RESEARCH, 1980, 28 (04): : A797 - A797
  • [6] Renoprotective Effects of Canagliflozin in Db/db Diabetic Mice
    Thanekar, Unmesha
    Gill, Rupinder K.
    Dhakal, Sanjeev
    Hosawi, Anhar
    Elased, Khalid M.
    [J]. HYPERTENSION, 2019, 74
  • [7] Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice
    Naito, Y
    Uchiyama, K
    Aoi, W
    Hasegawa, G
    Nakamura, N
    Yoshida, N
    Maoka, T
    Takahashi, J
    Yoshikawa, T
    [J]. BIOFACTORS, 2004, 20 (01) : 49 - 59
  • [8] Beneficial effects of phlorizin on diabetic nephropathy in diabetic db/db mice
    Pei, Fei
    Li, Bao-ying
    Zhang, Zhen
    Yu, Fei
    Li, Xiao-li
    Lu, Wei-da
    Cai, Qian
    Gao, Hai-qing
    Shen, Lin
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (05) : 596 - 603
  • [9] Beneficial Effects of Echinacoside on Diabetic Cardiomyopathy in Diabetic Db/Db Mice
    Zhang, Xiang
    Hao, Yarong
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 5575 - 5587
  • [10] Cardiovascular dysfunction and role of AT1 receptor in the development of hypertension in obese diabetic db/db mice
    Senador, Danielle
    Kanakamedala, Keerthy
    Moris, Mariana
    Elased, Khalid M.
    [J]. HYPERTENSION, 2007, 50 (04) : E135 - E136